You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mismatch allogeneic cell mediated immunotherapy

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ALS, Amyotrophic Lateral Sclerosis Trial in Scottsdale, Jacksonville, Rochester (Autologous Adipose-derived Mesenchymal Stromal

Active, not recruiting
  • ALS
  • Amyotrophic Lateral Sclerosis
  • Autologous Adipose-derived Mesenchymal Stromal Cells
  • Scottsdale, Arizona
  • +2 more
Oct 10, 2022

Multiple Sclerosis Trial in Ramat Gan (COVID-19 vaccination)

Recruiting
  • Multiple Sclerosis
  • COVID-19 vaccination
  • Ramat Gan, Israel
    Sheba Medical Center
Oct 6, 2021

Wound Heal, Tooth Extraction Status Nos Trial in Istanbul (Hyaluronic Acid Topical Gels, Diode Laser Biostimulation)

Enrolling by invitation
  • Wound Heal
  • Tooth Extraction Status Nos
  • Hyaluronic Acid Topical Gels
  • Diode Laser Biostimulation
  • Istanbul, Kağıthane, Turkey
    Istanbul Atlas University
Mar 1, 2023

COVID-19, Vaccine Reaction Trial in Oxford (Spermidine or Placebo)

Recruiting
  • COVID-19
  • Vaccine Reaction
  • Spermidine or Placebo
  • Oxford, United Kingdom
    University of Oxford
Jul 13, 2022

Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)

Recruiting
  • Large B-cell Lymphoma
  • DLBCL
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 3, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies Trial in United States (Orelabrutinib (ICP-022))

Recruiting
  • Part 1：r/r B-cell Malignancies
  • Part 2：B-cell Malignancies
  • Orelabrutinib (ICP-022)
  • Phoenix, Arizona
  • +26 more
Dec 7, 2021

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Nyack, New York
  • +100 more
Dec 12, 2021

Molecular Analysis Of Solid Tumors

Recruiting
  • Pediatric Solid Tumors
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Aug 25, 2021

    Lung Cancer, SCLC Trial in United States (Nivolumab, Plinabulin, Ipilimumab)

    Recruiting
    • Lung Cancer
    • SCLC
    • Duarte, California
    • +7 more
    Jan 18, 2023

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    NSCLC Trial in Ankara, Istanbul (RS-0139)

    Recruiting
    • NSCLC
    • Ankara, Turkey
    • +1 more
    Jan 17, 2022

    Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)

    Recruiting
    • Cardiovascular Diseases
    • Vascular Dilation
    • Ifetroban Sodium
    • Placebo
    • Worcester, Massachusetts
      University of Massachusetts Medical School
    Feb 16, 2022

    Red Blood Cell - IMProving trAnsfusions for Chronically

    Recruiting
    • Sickle Cell Disease
    • +2 more
    • Red Blood Cell (RBC) Transfusion
    • Oakland, California
    • +13 more
    Mar 18, 2022

    Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)

    Recruiting
    • Peripheral T Cell Lymphoma
    • ATLCAR.CD30 T cells
    • +3 more
    • Chapel Hill, North Carolina
    • +1 more
    Mar 4, 2022

    Clear Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab)

    Active, not recruiting
    Has Results
    • Clear Cell Renal Cell Carcinoma
    • Houston, Texas
      MD Anderson Cancer Center
    Apr 27, 2021

    NSCLC Stage III, NSCLC Stage II Trial in China (Dose-Painting Radiation)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • Non-small Cell Lung Cancer Stage II
    • Dose-Painting Radiation
    • Chengdu, Sichuan, China
    • +3 more
    Sep 1, 2021

    Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Cryoglobulinemic Vasculitis Trial (Isatuximab Injection)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Isatuximab Injection
    • (no location specified)
    Oct 28, 2021

    Rotator Cuff Tear, Muscle Atrophy, Tendon Tear Trial in New York (Autologous Stomal Vascular Fraction Material, Ringer's

    Recruiting
    • Rotator Cuff Tear
    • +2 more
    • Autologous Stomal Vascular Fraction Material
    • Ringer's solution
    • New York, New York
      Hospital for Special Surgery
    Jul 27, 2022

    Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, AMG 404)

    Recruiting
    • Small Cell Lung Cancer
    • Chicago, Illinois
    • +13 more
    Jul 27, 2022

    Diffuse Large B-cell Lymphoma, HIV Trial in Lilongwe (R-CHOP)

    Active, not recruiting
    • Diffuse Large B-cell Lymphoma
    • HIV
    • Lilongwe, Malawi
      UNC Project, Lighthouse Trust
    Oct 18, 2021

    Advanced Solid Tumors Trial in China, Korea, Republic of (Tislelizumab, Fruquintinib)

    Recruiting
    • Advanced Solid Tumors
    • Fuzhou, Fujian, China
    • +13 more
    Jun 29, 2022

    Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

    Not yet recruiting
    • Recurrent Acute Leukemia of Ambiguous Lineage
    • +5 more
    • Biospecimen Collection
    • +12 more
    • (no location specified)
    Mar 8, 2023

    Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic

    Recruiting
    • Colorectal Carcinoma
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 11, 2022

    Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

    Not yet recruiting
    • Recurrent Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Duarte, California
      City of Hope Medical Center
    Jul 31, 2022